Skip to textbook content
Doctor’s PassportTextbook
TopicsAll topics

Loading topic navigation…

Textbook navigation
TopicsAll topics

Loading topic navigation…
← Dermatology indexChapter sections
OverviewAetiologyPathophysiologyClinical features and red flagsInvestigationsDifferential diagnosisManagementComplicationsMonitoring and follow-upSpecial situationsCommon pitfallsQuestionsSources
Full textbook13 sectionsOpen only what you need
Educational draft · awaiting clinical reviewThe full textbook explains uncertainty but does not replace live national or local guidance, specialist advice, or current prescribing information.

Pityriasis rosea

Dermatology · UK scope · Sources checked 27 Aug 2026 · Clinical review pending

RapidFull
!
Time-critical presentation

A new rash during pregnancy, particularly in the first 15 weeks, requires immediate contact with the maternity unit, midwife, GP or NHS 111 for assessment rather than self-diagnosis.

Overview

Recognise the herald-patch and cleavage-line eruption, identify pregnancy and diagnostic exceptions, exclude tinea or secondary syphilis when indicated, and avoid overtreating a self-limiting rash.

Pityriasis rosea is a common self-limited papulosquamous eruption, most often in adolescents and young adults. Its diagnostic strength lies in the sequence and orientation of lesions rather than a single colour or scale descriptor.

The herald patch is a frequent source of error because it resembles tinea. Once secondary lesions appear, palms, soles, mucosae, medicine history, pregnancy and sexual-health context determine whether reassurance is safe.

Treatment is mainly explanation and itch control. A plan should set the expected time course, identify reasons for immediate or planned review and avoid antibiotics or antivirals as routine attempts to shorten benign disease.

Key points

  • Pityriasis rosea often starts with one 2 to 5 cm scaly herald patch on trunk or proximal limb, followed days to two weeks later by many smaller oval scaly lesions.
  • Secondary lesions align with cleavage lines, forming a fir-tree distribution across the back; a herald patch is helpful but not present or recognised in every case.
  • On brown or black skin, lesions may be deep brown or have a lighter border rather than look pink, and post-inflammatory lighter or darker marks may last for months.
  • Palms, soles, face and mucosae are usually spared; involvement there, systemic illness, drug timing or sexual risk should redirect the differential.
  • Diagnosis is clinical when the sequence is typical. Scrape a solitary annular herald-like patch for fungus when uncertain, and use syphilis serology when history or distribution supports it.
  • Most eruptions resolve in six to eight weeks or within a few months, need no specific treatment and do not require school exclusion.
  • For discomfort, use fragrance-free emollient or soap substitute, an appropriate antihistamine, and prescribed mild topical corticosteroid; BAD describes hydrocortisone ointment twice daily for troublesome itch.
  • Any new rash during pregnancy needs immediate maternity, GP or NHS 111 contact, especially in the first 15 weeks.

Aetiology

01

Uncertain trigger

The exact cause is unknown. Reactivation of human herpesvirus 6 or 7 has been proposed, but routine viral testing is not diagnostic and the eruption is not managed as herpes simplex.

02

Low transmission

Cases may cluster and a viral association is suspected, yet person-to-person spread is considered very unlikely. Children do not need school exclusion solely for pityriasis rosea.

03

Medicine-related mimic

Several medicines can produce a pityriasis-rosea-like eruption that lacks a classic herald sequence or lasts longer. A timeline matters more than assuming every cleavage-line rash is idiopathic.

Pathophysiology

  1. 1
    Transient inflammatory eruption

    A self-limited cutaneous immune response produces superficial inflammation and fine scale. It usually resolves without scar because epidermal injury is limited.

  2. 2
    Cleavage-line orientation

    Secondary oval lesions align with skin tension lines on the trunk, creating the characteristic fir-tree pattern on the back. Orientation is more reliable than pink colour alone.

  3. 3
    Pigment after inflammation

    Melanin alteration can leave temporary hyperpigmentation or hypopigmentation after scale and elevation resolve. This is particularly visible in darker skin and may persist for months without scarring.

Clinical features and red flags

Herald patch

One larger oval patch with a peripheral collarette of fine scale appears on trunk, neck or proximal limb before the generalised phase. It can be absent, unnoticed or confused with dermatophyte infection.

Fir-tree eruption

Crops of smaller oval lesions follow cleavage lines on trunk and proximal limbs, producing a fir-tree appearance across the back. Hands, feet and face are unusual sites.

Mild prodrome and itch

Headache, tiredness, sore throat or low fever may precede the rash, and itch varies from absent to troublesome. Marked systemic illness is atypical and needs another explanation.

Appearance in darker skin

Patches may look brown, dusky or violaceous with a lighter scaly rim. Papules can be more prominent, and residual hyperpigmentation or hypopigmentation can persist after active scale disappears.

Pregnancy warningRed flag

A new rash in pregnancy must not be self-labelled. NHS advises immediate contact with maternity care, GP or NHS 111 because early-pregnancy pityriasis rosea has reported adverse associations.

Atypical distributionRed flag

Palms, soles, mucosae, prominent face involvement, vesicles, purpura, pain or lesions persisting beyond the expected course should trigger targeted investigation or referral.

Red flags requiring action

  • Pregnancy with a new pityriasis-rosea-like rash needs immediate maternity or clinical assessment because early-pregnancy disease has been linked with miscarriage and preterm birth.

Investigations

  1. 01
    First-line chronology and complete skin examinationFirst stepFirst line
    Why
    Confirm a herald lesion followed by cleavage-line secondary eruption and identify atypical palms, soles or mucosae.
    Interpretation and limitations
    A classic sequence in a well person is usually diagnostic without tests. Missing herald patch lowers neither safety nor certainty enough to ignore conflicting distribution.
  2. 02
    Fungal scraping from an active scaly edge
    Why
    Distinguish a solitary herald-like patch or atypical annular lesion from tinea corporis.
    Interpretation and limitations
    Microscopy may give early support and culture is slower; collect before antifungal treatment when possible and reconsider sampling quality if suspicion remains after a negative result.
  3. 03
    Syphilis serology with sexual-health assessment
    Why
    Exclude secondary syphilis when palms, soles, mucosae, lymph nodes, systemic features or exposure history raise probability.
    Interpretation and limitations
    Use validated treponemal testing and interpret with stage and prior treatment through sexual-health services; obtain consent and avoid stigmatising assumptions.
  4. 04
    Pregnancy assessment and gestational age
    Why
    Route a new rash promptly and define whether the first-15-week risk window applies.
    Interpretation and limitations

Differential diagnosis

01

Tinea corporis

A herald patch can resemble ringworm, but tinea usually has an advancing scaly border and progressive local expansion. Scrape the active margin when a solitary patch remains uncertain.

02

Secondary syphilis

Systemic symptoms, generalised lymph nodes, mucous patches and palm or sole involvement raise concern. Take a respectful sexual history and arrange validated serology rather than relying on rash appearance.

03

Guttate psoriasis

Guttate psoriasis has many small scaly papules, often after sore throat, without the classic herald-patch sequence. Scalp, nail and extensor psoriasis support that alternative.

04

Drug eruption

A new medicine, prominent itch, facial involvement, eosinophilia or prolonged course may indicate a drug-related pityriasiform rash. Mucosal injury or organ symptoms require urgent severe-reaction assessment.

05

Other truncal eruptions

Nummular eczema, pityriasis lichenoides, viral exanthem, cutaneous T-cell lymphoma and superficial fungal disease enter the differential when age, morphology, symptoms or duration are discordant.

Management

01First-lineTypical uncomplicated eruptionFirst stepFirst lineClassic herald sequence and cleavage-line rash in a well, non-pregnant person without atypical sites.+
  1. 1Explain that the eruption is not usually contagious, often peaks before improving, and commonly settles in six to eight weeks or within a few months without scar.
  2. 2No active treatment is needed if comfortable; continue school, work and ordinary contact, and avoid irritant soap or unnecessary antimicrobial treatment.
  3. 3For itch, use fragrance-free emollient or soap substitute and an appropriate antihistamine; add a short mild topical corticosteroid course if symptoms remain troublesome.
  4. 4Advise review if the rash has not resolved by three months, becomes painful or blistered, involves mucosae, palms or soles, or systemic symptoms develop.
02Diagnostic branch

Complications

01

Pregnancy-associated risk

NHS advice highlights an association between pityriasis rosea in the first 15 weeks and miscarriage or premature birth. A new rash in pregnancy therefore needs immediate clinical contact.

02

Post-inflammatory dyspigmentation

Darker or lighter macules can outlast the eruption for months, especially in skin of colour. They fade gradually and do not represent contagion or usually permanent scar.

03

Sleep-disrupting itch

Although usually mild, pruritus can impair sleep and concentration. Symptom severity determines supportive treatment and occasional dermatology escalation rather than lesion count alone.

04

Diagnostic delay

The most important harm is mislabelling secondary syphilis, tinea, drug reaction or inflammatory disease as benign pityriasis rosea. Atypical sites and persistence should reopen assessment.

Monitoring and follow-up

  • Provide an expected six-to-eight-week trajectory and review if lesions persist beyond three months, spread to unusual sites, become painful or blistered, or systemic symptoms appear.
  • Ask whether scale and elevation are resolving separately from pigment; temporary lighter or darker macules can remain for months and usually need reassurance and photoprotection.
  • During symptomatic topical treatment, review quantity, site, infection and adverse effects rather than continuing hydrocortisone automatically because colour persists.
  • For pregnancy, ensure immediate maternity contact occurred and that gestational age, diagnostic assessment and obstetric follow-up are documented.
  • If syphilis or fungal tests were taken, assign responsibility for results, confidential communication, partner or public-health actions where relevant and treatment completion.

Special situations

Sequence beats snapshot

A photograph of one annular patch can look fungal. The later crop of smaller cleavage-line lesions transforms diagnostic probability, so chronology belongs in the examination.

Collarette scale

Fine scale trails just inside the lesion edge rather than forming the advancing external border typical of many dermatophyte plaques. Sampling still resolves genuine uncertainty.

Colour follows skin tone

The name rosea should not force a pink criterion. Brown, dusky or violaceous lesions with a lighter rim can express the same morphology.

Palms change the differential

Palmar or plantar lesions are unusual enough to prompt secondary syphilis, drug eruption, psoriasis and other causes rather than routine reassurance.

Pregnancy changes urgency

A benign course in most patients does not justify self-diagnosis during pregnancy. Gestation and alternative exanthems need immediate clinical assessment.

Common pitfalls

  1. 01

    Calling a single herald-like patch pityriasis rosea without considering tinea or waiting for the diagnostic sequence.

  2. 02

    Using pinkness as a required sign and missing brown or violaceous lesions in darker skin.

  3. 03

    Reassuring a pregnant patient with a new rash without immediate maternity or clinical contact.

  4. 04

    Missing secondary syphilis when palms, soles, mucosae or lymph nodes are involved.

  5. 05

    Prescribing routine antibiotics or antivirals to every case despite spontaneous resolution and limited evidence.

  6. 06

    Treating persistent pigment with ongoing corticosteroid after active scale and itch resolve.

Practice

Two practice questions

Your practice draft is saved in this browser.

Question 1 of 2
0 correct
DermatologyOriginal SBA

Atypical palm involvement

A patient labelled with pityriasis rosea has a widespread scaly eruption involving both palms, generalised lymphadenopathy and a new sexual partner. What is the best next investigation?

Choose one answer, then submit
← Rapid synopsisBack to overviewAll Dermatology topics →
Sources and review status4 sources · checked 27 Aug 2026 · clinical review pending+
Sources

Sources and review status

National guidance is shown before implementation-dependent detail. Typical adult dose examples remain subject to patient factors, contraindications and the live BNF or specialist protocol. Source check completed 27 Aug 2026; clinical approval remains outstanding.

  • British Association of Dermatologists: pityriasis rosea
  • NHS: pityriasis rosea
  • Hydrocortisone ointment Summary of Product Characteristics
  • MHRA: safe use of emollient skin creams

Editorial contact: Doctor’s Passport editorial team. Source-check date is separate from clinical approval. Report a content problem · Content changes

Authoring stateComplete draftClinical stateAwaiting reviewJurisdictionUnited Kingdom
Palmar or plantar lesions, mucosal patches, lymphadenopathy, neurological symptoms or sexual risk should prompt testing for secondary syphilis and other systemic mimics.
  • Skin pain, dusky targets, blisters, mucosal erosions, facial oedema or systemic organ symptoms suggests a severe drug reaction rather than uncomplicated pityriasis rosea.
  • Persistence beyond three months, marked constitutional illness, ulceration or progressive atypical morphology warrants diagnosis review and possible dermatology assessment.
    • Contact maternity or appropriate clinical services immediately rather than waiting for a dermatology test; confirm the rash diagnosis and assess maternal-fetal needs.
  • 05
    Skin biopsy for persistent or discordant disease
    Why
    Exclude psoriasis, pityriasis lichenoides, drug eruption or cutaneous lymphoma when the course exceeds about two to three months or morphology is atypical.
    Interpretation and limitations
    Histology can support a pattern but is not uniquely diagnostic. Sample a representative active lesion with consent and provide duration, medicine timeline and differential.
    • Atypical or solitary lesions
    No convincing sequence, unusual distribution, prolonged course or conflicting systemic history.
    +
    1. 1Scrape an active edge for mycology when tinea is plausible and take a full medicine timeline before applying corticosteroid that could alter morphology.
    2. 2Offer syphilis testing through an appropriate confidential pathway when palmoplantar, mucosal, lymph-node or sexual-history features support it.
    3. 3Refer or biopsy when disease persists beyond the expected course, remains diagnostically uncertain or has ulceration, marked systemic illness or progressive change.
    03PregnancyImmediate maternity contactAny new pityriasis-rosea-like rash during pregnancy.+
    1. 1Advise immediate contact with the midwife, maternity unit, GP or NHS 111, recording gestation and systemic symptoms.
    2. 2Confirm the diagnosis and exclude drug reaction, infection and other exanthems rather than offering reassurance from an image alone.
    3. 3Coordinate obstetric follow-up, especially in the first 15 weeks, and choose symptom treatment compatible with pregnancy after individual review.
    04EscalationSevere itch or extensive persistent rashEscalationSleep-disrupting symptoms despite simple measures or an unusually severe course.+
    1. 1Recheck the diagnosis, exposure and pregnancy status, and assess for secondary infection caused by scratching.
    2. 2A clinician may use a stronger but site-appropriate topical corticosteroid or refer for supervised ultraviolet treatment; balance treatment burden against spontaneous resolution.
    3. 3BAD notes limited evidence for early aciclovir or erythromycin, but these are rarely required and should not be routine primary-care clearance regimens.
    Key medicines and prescribing safety3 treatments · regimens, roles and cautions+
    Mild topical corticosteroid for short symptomatic relief; BAD specifically describes hydrocortisone ointment twice daily when pityriasis rosea remains uncomfortable.

    Hydrocortisone 1% ointment

    Apply a small amount evenly and sparingly to itchy affected skin once or twice daily for no longer than 1 week, then stop and reassess if still needed.

    This product use is symptom-directed and may be off-label for the rash; avoid eyes, untreated infection, extensive occlusion and prolonged courses, especially in children.

    Reduces irritation and supports comfort while spontaneous resolution occurs without implying that moisturiser shortens the disease course.

    Fragrance-free emollient or soap substitute

    Apply generously as often as needed for dryness and itch and use in place of soap or shower gel on affected skin.

    Residue on clothing and bedding increases fire severity even after drying; avoid flames and smoking, wash fabrics frequently and beware slippery floors.

    May reduce itch for some people but does not alter the underlying eruption or its expected duration.

    Non-sedating oral antihistamine

    Use the licensed adult dose of the selected product for the shortest symptomatic period, adjusting for age, pregnancy, renal function and interactions.

    Check the specific product for sedation and driving advice, avoid duplicate antihistamines, and seek clinical review rather than escalating repeatedly when itch persists.